Mature Reproductive Age

Mature reproductive age is a clinical designation for women aged 35 and older who are attempting pregnancy, acknowledging that fertility potential, egg quality, and time-to-pregnancy change meaningfully as the ovarian reserve established before birth continues its decline, at an accelerating pace through the mid-thirties and beyond. The designation does not imply a fertility cliff. It signals that a couple presenting at this stage benefits from greater clinical urgency and diagnostic depth.

The biological changes are real and measurable. Oocyte aneuploidy rates rise with age, extending time-to-pregnancy and increasing early pregnancy loss. AMH and antral follicle count both decline, reflecting the shrinking ovarian follicle pool, though among women without a history of infertility, declining reserve markers alone have not been shown to predict a reduced chance of conceiving.1 Cycle regularity may remain intact while egg quality and fertilization potential fall. These changes confront every clinician working with older reproductive-age couples, regardless of the care model.

Restorative care produces meaningful outcomes in this population. A 2025 single-center cohort study of 1,310 infertile couples treated with NaProTechnology, in which the mean age of women was 35.0 years (SD 4.4), reported an adjusted cumulative take-home baby rate of 62.1%. Age-stratified rates were 53.3% for women aged 36 to 40 and 24.4% for women over 40.2 These results came from a population with unfavorable prognostic factors, including prolonged infertility duration and prior ART attempts in more than a quarter of couples. Both partners receive evaluation from the outset; male factor is solely responsible in approximately 20% of infertile couples and contributes in an additional 30 to 40%.3

Cited in this entry

  1. Steiner AZ et al. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age. JAMA. 2017. JAMA. https://rrmacademy.org/library/association-between-biomarkers-of-ovarian-reserve-and-infertility-among-older-wo-reckxs7k83ltnbrhv/
  2. NaProTechnology for infertility: take-home baby rate and clinical outcomes in a 5-year single-center cohort. PubMed. https://pubmed.ncbi.nlm.nih.gov/41323405/
  3. Schlegel PN, Sigman M, Collura B, et al. Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline Part I. J Urol. 2021;205(1):36-43. The Journal of Urology. https://pubmed.ncbi.nlm.nih.gov/33295257/

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.